Vistagen therapeutics reports third quarter financial results and provides corporate update

South san francisco, calif., feb. 10, 2022 (globe newswire) --   vistagen therapeutics, inc . (nasdaq: vtgn), a company developing therapeutics to transform the treatment paradigm for patients suffering from anxiety, depression and other central nervous system (cns) disorders, today reported results for its third fiscal quarter ended december 31, 2021 and provided a corporate update.
VTGN Ratings Summary
VTGN Quant Ranking